MindMed company

MindMed discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering. The company is actively acquiring or forming collaborations for new clinical trials of hallucinogenic doses of psychedelics through human clinical trials. MindMed was founded by JR Rahn, Scott Freeman, and Stephen L. Hurst in 2010.

Investors

Technology: NeuroTech
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Toronto, Ontario, Canada
Founded Date: 2010-01-01
Employees Number: 1-10
Funding Status: IPO
Investors Number: 3
Total Funding: $30.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
info@mindmed.co
https://twitter.com/mindmedco
Register and Claim Ownership